Pre-exposure prophylaxis to prevent HIV infection — aka PrEP — is very effective, writes Chris Tachibana (@ChrisTachibana), but only a quarter of eligible Americans take it, and uptake is lower in particular groups. In her piece for the University of Pennsylvania Leonard Davis Institute of Health Economics, Tachibana talks with researchers and health care providers about evidence-based methods for making this lifesaving medication easier to access, especially for the most vulnerable people. Providing nonjudgemental information about PrEP via trusted messengers and as part of routine sexual health care could help increase uptake, she reports, as could increasing the use of telehealth services to prescribe it. Photo by Tony Webster via Wikimedia Commons
